| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |